CNR1 and myeloid sarcoma: Although it is generally believed that CB2R plays a key role in the anti-inflammatory effects of the eCB system, CB1R overexpression in lumbar spinal cord delayed the onset of clinical symptoms and attenuated clinical score and demyelination in an MS model induced by MOG peptide immunization (114).